Omega-3-acid ethyl esters
- Generic Name
- Omega-3-acid ethyl esters
- Brand Names
- Lovaza, Omtryg
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 308081-97-2
- Unique Ingredient Identifier
- D87YGH4Z0Q
- Background
Omega-3-acid ethyl esters are prescription drugs that contain eicosapentaenoic acid-ethyl ester (EPA) and docosahexaenoic acid-ethyl ester (DHA) that are used in combination with changes in diet to lower triglyceride levels in adults with severe (≥ 500 mg/dL) hypertriglyceridemia. Omega-3-acid ethyl esters are currently marketed in the US, EU, and many other...
- Indication
Omega-3-Acid Ethyl Esters capsules, USP are indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia (HTG).
- Associated Conditions
- Severe Hypertriglyceridemia (sHTG)
- Associated Therapies
- -
The Impact of Omega Three Fatty Acids on Vascular Function in HIV
- First Posted Date
- 2009-12-31
- Last Posted Date
- 2020-02-11
- Lead Sponsor
- Tufts University
- Target Recruit Count
- 129
- Registration Number
- NCT01041521
- Locations
- 🇺🇸
Tufts University School of Medicine, Boston, Massachusetts, United States
Pilot Placebo Controlled Study With Lovaza in Cardiovascular Disease
- First Posted Date
- 2009-10-27
- Last Posted Date
- 2015-01-07
- Lead Sponsor
- University Hospitals Cleveland Medical Center
- Target Recruit Count
- 35
- Registration Number
- NCT01001767
- Locations
- 🇺🇸
University Hospitals of Cleveland Case Medical Center, Cleveland, Ohio, United States
Effects of Lovaza on Lipoprotein Composition and Function in Mild Hypertriglyceridemia
- First Posted Date
- 2009-08-17
- Last Posted Date
- 2021-10-20
- Lead Sponsor
- Sanford Research
- Target Recruit Count
- 15
- Registration Number
- NCT00959842
- Locations
- 🇺🇸
Sanford Research/USD, Sioux Falls, South Dakota, United States
Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease
- First Posted Date
- 2009-07-17
- Last Posted Date
- 2010-06-10
- Lead Sponsor
- Huntington Medical Research Institutes
- Target Recruit Count
- 40
- Registration Number
- NCT00941642
- Locations
- 🇺🇸
HMRI - Liver Center, Pasadena, California, United States
Triglyceride Lowering Study
- First Posted Date
- 2009-07-08
- Last Posted Date
- 2009-07-08
- Lead Sponsor
- Jewish Hospital, Cincinnati, Ohio
- Target Recruit Count
- 25
- Registration Number
- NCT00934219
- Locations
- 🇺🇸
Jewish Hospital Cholesterol Center, Cincinnati, Ohio, United States
Fish Oil Study for High Triglyceride Levels in Children
- Conditions
- Interventions
- First Posted Date
- 2009-06-08
- Last Posted Date
- 2022-11-08
- Lead Sponsor
- Babu Balagopal
- Target Recruit Count
- 42
- Registration Number
- NCT00915902
- Locations
- 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸A. I. duPont Hospital for Children, Wilmington, Delaware, United States
🇺🇸Thomas Jefferon University, Philadelphia, Pennsylvania, United States
Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
- Conditions
- Interventions
- First Posted Date
- 2009-02-02
- Last Posted Date
- 2017-07-02
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 65
- Registration Number
- NCT00833976
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial
- First Posted Date
- 2008-11-21
- Last Posted Date
- 2019-09-11
- Lead Sponsor
- Tufts University
- Target Recruit Count
- 41
- Registration Number
- NCT00795717
- Locations
- 🇺🇸
Tufts University School of Medicine, Boston, Massachusetts, United States
Effects of Fish Oil on Post Ablation Arrhythmias
- Conditions
- Interventions
- First Posted Date
- 2008-11-14
- Last Posted Date
- 2017-09-12
- Lead Sponsor
- University of Michigan
- Target Recruit Count
- 12
- Registration Number
- NCT00791089
- Locations
- 🇺🇸
University of Michigan Cardiovascular Center, Ann Arbor, Michigan, United States
The Effects of Omega-3 Fatty Acids on Aspirin Resistance
- Conditions
- Interventions
- First Posted Date
- 2008-10-15
- Last Posted Date
- 2012-11-06
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 27
- Registration Number
- NCT00771914
- Locations
- 🇺🇸
University of Rochester School of Medicine and Dentistry, Rochester, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.